These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 11495389)
1. Harbinger of hope or commodity fetishism: "re-cognizing" dementia in an age of therapeutic agents. Graham JE Int Psychogeriatr; 2001 Jun; 13(2):131-4. PubMed ID: 11495389 [No Abstract] [Full Text] [Related]
2. Utilization of the Dementia Rating Scale-2 and cognitive enhancers in the diagnosis and treatment of cognitive disorders and dementia. Caston JC; Diehl LA; Hedgepath AW J S C Med Assoc; 2004 Feb; 100(2):32-8. PubMed ID: 15040232 [No Abstract] [Full Text] [Related]
3. France removes state funding for dementia drugs. Walsh S; King E; Brayne C BMJ; 2019 Dec; 367():l6930. PubMed ID: 31888870 [No Abstract] [Full Text] [Related]
4. Restriction in complex activities of daily living in MCI: impact on outcome. Hussain H Neurology; 2007 May; 68(18):1544-5; author reply 1545. PubMed ID: 17470764 [No Abstract] [Full Text] [Related]
5. NICE and anti-dementia drugs: a triumph of health economics over clinical wisdom? O'Brien JT Lancet Neurol; 2006 Dec; 5(12):994-6. PubMed ID: 17110274 [No Abstract] [Full Text] [Related]
6. Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Gauthier S; Bodick N; Erzigkeit E; Feldman H; Geldmacher DS; Huff J; Mohs R; Orgogozo JM; Rogers S Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():6-7. PubMed ID: 9305507 [No Abstract] [Full Text] [Related]
8. [Chief psychiatric problems in old age]. Stoppe G Internist (Berl); 2000 Jun; 41(6):538-43. PubMed ID: 10907186 [No Abstract] [Full Text] [Related]
9. Antidementia drugs: are they effective in improving quality of life for elderly persons with dementia? Homma A Int Psychogeriatr; 1995; 7(3):363-6. PubMed ID: 8821343 [No Abstract] [Full Text] [Related]
10. Neurotrophic factor treatment of neurological disorders: the benefits of a pleiotropic treatment approach. Commentary. Muresanu DF; Doppler E; Novak P CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):415-6. PubMed ID: 21495957 [No Abstract] [Full Text] [Related]
11. Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Winblad B; Hill S; Beermann B; Post SG; Wimo A Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():39-45. PubMed ID: 9305515 [No Abstract] [Full Text] [Related]
15. Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatment. Desai AK; Grossberg GT; Sheth DN CNS Drugs; 2004; 18(13):853-75. PubMed ID: 15521790 [TBL] [Abstract][Full Text] [Related]
16. [When should the brain imaging be done in suspected dementia?]. Soininen H; Sulkava R Duodecim; 2000; 116(10):1037-8. PubMed ID: 11989014 [No Abstract] [Full Text] [Related]
17. First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary. Whitehouse PJ; Winblad B; Shostak D; Bhattacharjya A; Brod M; Brodaty H; Dor A; Feldman H; Forette F; Gauthier S; Hay J; Henke C; Hill S; Mastey V; Neumann P; O'Brien B; Pugner K; Sano M; Sawada T; Stone R; Wimo A Alzheimer Dis Assoc Disord; 1998 Dec; 12(4):266-80. PubMed ID: 9876955 [TBL] [Abstract][Full Text] [Related]
18. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N Health Technol Assess; 2001; 5(1):1-137. PubMed ID: 11262420 [TBL] [Abstract][Full Text] [Related]
19. Dementia with Lewy bodies: response of delirium-like features to donepezil. Kaufer DI; Catt KE; Lopez OL; DeKosky ST Neurology; 1998 Nov; 51(5):1512. PubMed ID: 9818904 [No Abstract] [Full Text] [Related]